LifeMD, Inc. — Director's Dealing 2022

Feb 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-02-04

Reporting Person: STAN MARIA E. (Principal Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-04	Common Stock	M	5000	—	Acquired	8125	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-04	Restricted Stock Unit	$0	A	15000	Acquired		Common Stock (15000)	Direct
2022-02-04	Restricted Stock Unit	$	M	5000	Disposed		Common Stock (5000)	Direct

Footnotes

F1: 5,000 RSUs vested on February 4, 2022. Of the remaining RSUs, 5,000 vest on February 4, 2023 and 5,000 RSUs vest on February 4, 2024.

F2: Restricted stock units convert into common stock on a one-for-one basis.